+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antibody Library Technologies - Global Strategic Business Report

  • PDF Icon

    Report

  • 197 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5309393
The global market for Antibody Library Technologies was estimated at US$190.4 Million in 2023 and is projected to reach US$249.6 Million by 2030, growing at a CAGR of 3.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Antibody library technologies have become a cornerstone in modern biotechnology, particularly in the field of therapeutic antibody discovery and development. These technologies involve creating vast collections of antibody variants, known as libraries, which can be screened to identify those with the desired properties for treating diseases. Phage display, one of the most prominent antibody library technologies, allows for the rapid and efficient selection of high-affinity antibodies from large pools of variants. This method has revolutionized drug discovery, enabling the development of monoclonal antibodies that are used to treat a variety of conditions, including cancers, autoimmune diseases, and infectious diseases. The ability to quickly identify potent antibodies from these libraries accelerates the drug development process and enhances the likelihood of clinical success.

How Are Technological Advancements Shaping Antibody Library Technologies?

Technological advancements are significantly enhancing the capabilities and efficiency of antibody library technologies. Next-generation sequencing (NGS) has transformed the way antibody libraries are constructed and analyzed, allowing researchers to comprehensively characterize and optimize antibody repertoires. Additionally, advancements in synthetic biology have enabled the creation of highly diverse and tailored libraries that can target specific antigens with greater precision. Artificial intelligence (AI) and machine learning are also being integrated into the screening process, improving the accuracy and speed of antibody selection. These technologies not only streamline the discovery process but also reduce costs and increase the potential for finding novel therapeutic antibodies. The integration of these cutting-edge technologies is driving innovation and expanding the applications of antibody library technologies in drug discovery.

Why Are Antibody Library Technologies Essential for Personalized Medicine?

Antibody library technologies are essential for the advancement of personalized medicine, which aims to tailor treatments to individual patients based on their genetic and molecular profiles. By utilizing highly diverse antibody libraries, researchers can identify antibodies that are specifically effective against the unique biomarkers present in a patient's disease. This approach enhances the efficacy and reduces the side effects of treatments, offering a more targeted and personalized therapeutic strategy. The ability to rapidly screen and identify antibodies that bind to rare or previously undruggable targets is particularly valuable in the development of treatments for complex and refractory diseases. The ongoing research and development efforts in this field are focused on creating antibodies that can be customized to meet the specific needs of individual patients, thereby improving treatment outcomes.

What Factors Are Driving Growth in the Antibody Library Technologies Market?

The growth in the antibody library technologies market is driven by several factors related to technological advancements, expanding applications, and evolving industry demands. The increasing investment in biotechnology and pharmaceutical research is a major driver, as companies seek to develop innovative antibody-based therapies. Advances in next-generation sequencing and synthetic biology are enhancing the creation and screening of antibody libraries, making these technologies more efficient and effective. The rising demand for personalized medicine, with its focus on tailored treatments, is expanding the addressable market for antibody library technologies. Additionally, the growing prevalence of chronic diseases and the need for new therapeutic options are driving the adoption of these technologies. Strategic collaborations and partnerships in research and development are fostering innovation and expanding the applications of antibody libraries. The integration of AI and machine learning in the antibody selection process is also accelerating market growth by improving the speed and accuracy of antibody discovery. Collectively, these factors are shaping a dynamic and rapidly evolving market landscape for antibody library technologies.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Drug Discovery & Development Application segment, which is expected to reach US$171.1 Million by 2030 with a CAGR of a 4.1%. The Research Application segment is also set to grow at 3.8% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $51.5 Million in 2023, and China, forecasted to grow at an impressive 3.7% CAGR to reach $39.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Antibody Library Technologies Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Antibody Library Technologies Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Antibody Library Technologies Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abcam PLC, AbCheck s.r.o., Abgent, Inc., a WuXi AppTec company, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 47 Featured):

  • Abcam PLC
  • AbCheck s.r.o.
  • Abgent, Inc., a WuXi AppTec company
  • Abwiz Bio Inc.
  • Abzena PLC
  • Adimab LLC
  • AnaptysBio, Inc.
  • AvantGen, Inc.
  • Creative-biolabs
  • Dyax Corporation
  • Invenra, Inc.
  • MorphoSys AG
  • Philogen S.p.A.
  • Vaccinex Inc.
  • Xoom Corporation

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Antibody Library Technologies - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Investment in Biotechnology Throws the Spotlight on Antibody Library Technologies
  • Advances in Next-Generation Sequencing Propel Growth in Antibody Discovery
  • Rising Demand for Personalized Medicine Expands Addressable Market Opportunity
  • Development of Phage Display Libraries Strengthens Business Case for Rapid Screening
  • Innovations in Synthetic and Human Antibody Libraries Generate New Market Opportunities
  • Growth in Monoclonal Antibody Therapies Drives Demand for Advanced Library Technologies
  • Focus on Rare and Undruggable Targets Impacts Antibody Library Utilization
  • Adoption of Artificial Intelligence and Machine Learning Enhances Antibody Selection Processes
  • Growing Interest in Bispecific and Multispecific Antibodies Drives Adoption of Library Technologies
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Phage Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Phage Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Phage Display by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Ribosome Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Ribosome Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Ribosome Display by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Yeast Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Yeast Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Yeast Display by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Mammalian Cell Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Mammalian Cell Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Mammalian Cell Display by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 15: World 16-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 18: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 21: World 16-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 24: World 16-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 27: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Contract Research Organization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Contract Research Organization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 30: World 16-Year Perspective for Contract Research Organization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 31: World Antibody Library Technologies Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Antibody Library Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Antibody Library Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 34: World 16-Year Perspective for Antibody Library Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
CANADA
JAPAN
  • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
EUROPE
  • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
FRANCE
  • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Antibody Library Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned

  • Abcam PLC
  • AbCheck s.r.o.
  • Abgent, Inc., a WuXi AppTec company
  • Abwiz Bio Inc.
  • Abzena PLC
  • Adimab LLC
  • AnaptysBio, Inc.
  • AvantGen, Inc.
  • Creative-biolabs
  • Dyax Corporation
  • Invenra, Inc.
  • MorphoSys AG
  • Philogen S.p.A.
  • Vaccinex Inc.
  • Xoom Corporation

Table Information